TREATMENT NUCLEIC ACIDS

Brand Owner (click to sort) Address Description
CHIPMENTATION CeMM - Forschungszentrum für MolekulareMedizin GmbH Lazarettgasse 14, AKH BT 25.3 Vienna A-1090 Austria Treatment of nucleic acids, proteins and chromatin; treatment of nucleic acids with enzymatic reactions; treatment of chromatin with enzymatic reactions; treatment of nucleic acids for sequencing;Apparatus, namely, column- and magnet-based apparatus for chromatin immunoprecipitation, chromatin analysis, chromatin purification, nucleic acid purification and analysis for laboratory use; scientific, electric, photographic, optical, measuring apparatus, namely, sequencers for next generation genetic sequencing for laboratory use; scientific, electric apparatus preparing nucleic acids for sequencing for laboratory use; computer hardware and computer software for processing and displaying and interpreting data, in particular for scientific purposes; testing apparatus for testing samples comprising a nucleic acid for for diagnostic purposes, other than medical purposes;Chemical preparations for use in DNA analysis other than for medical use; reagents for use in scientific apparatus for chemical or biological analysis; biomolecule labeling kits comprising reagents for use in scientific research; chemicals for use in immuno-assay testing other than for medical or veterinary use; in-vivo diagnostic reagents for scientific use; diagnostic testing preparations, other than for medical use; diagnostic preparations, except for medical or veterinary use; diagnostic reagents, other than for medical laboratory use; diagnostic reagents, except for medical or veterinary use; diagnostic reagents for in-vitro use, other than for medical use; diagnostic chemicals, other than for medical or veterinary use; diagnostic preparations, other than for medical or veterinary purposes; clinical diagnostic preparations, other than for medical or veterinary use; diagnostic reagents and preparations, except for medical or veterinary use; diagnostic reagents, other than for medical use for sale in kit form; diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology; diagnostic preparations for scientific or research use other than for medical use; reagents for use in diagnostic tests, other than for medical or veterinary purposes; chemical reagents for use in diagnostic tests, other than for medical or veterinary use; diagnostic substances in the nature of chemicals and preparations, other than for medical use; diagnostic reagents for scientific or research use; diagnostic preparations for scientific or research use; biochemical products, in particular biochemicals used in industry and science to study cells, chromatin, proteins, nucleic acids, protein-nucleic acid interactions, other than for medical use; biochemical reagents and chemical reagents, in particular biochemical reagents and chemical reagents for in-vitro use in laboratories for scientific use;Scientific research and development services; industrial research in the field of biology; industrial research in the field of human biology and diseases like cancer and inflammation and immune disorders; laboratory services for detecting protein-DNA interactions; Laboratory analysis relating to protein-DNA interactions; computer programming; DNA screening for scientific research purposes; biochemical analysis; biological analysis; preparation of biological samples for analysis in research laboratories; preparation of biological samples for testing and analysis in research laboratories; research and development in the field of diagnostic preparations;
IDPOOL IDgene Pharmaceuticals Ltd. Jerusalem 91344 United States Treatment of nucleic acids for the purpose of determining genetic variation;Chemicals used for genotyping and DNA analysis.;Genetic research services, namely, genotyping services and determining the genetic association between genetic markers and common diseases or drug response;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. Novel nucleic acids associated with Type 1 diabetes. Also provided are polypeptides encoded by the nucleic acids associated with T1D. The invention also provides methods for facilitating the diagnosis or pre-diagnosis of T1D through the use of such nucleic acids and polypeptides. This invention further provides compositions for the treatment of Type 1 diabetes.